CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
Sponsor: VA Office of Research and Development • ClinicalTrials.gov ID: NCT05931276
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The investigators aim to determine, using a point-of-care randomized controlled trial design, if hemodialysis patients, who are randomized to metoprolol succinate (a dialyzable, beta-1 selective beta blocker), have an improved cardiovascular outcome compared to those randomized to carvedilol (a non-dialyzable, non-selective beta blocker with alpha-1 antagonist properties). The investigators will also examine intervention practices to identify components that best support engagement and sustainability.
Interventions
-
Metoprolol Succinate
(Drug)
a dialyzable, beta-1 selective beta blocker
-
Carvedilol
(Drug)
a non-dialyzable, non-selective beta blocker with alpha-1 antagonist properties
Eligibility criteria
Conditions
Locations
- VA Long Beach Healthcare System, Long Beach, CA — Long Beach, California, United States
- Rocky Mountain Regional VA Medical Center, Aurora, CO — Aurora, Colorado, United States
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT — West Haven, Connecticut, United States
- North Florida/South Georgia Veterans Health System, Gainesville, FL — Gainesville, Florida, United States
- Atlanta VA Medical and Rehab Center, Decatur, GA — Decatur, Georgia, United States
- Jesse Brown VA Medical Center, Chicago, IL — Chicago, Illinois, United States
- Iowa City VA Health Care System, Iowa City, IA — Iowa City, Iowa, United States
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA — Boston, Massachusetts, United States
- Minneapolis VA Health Care System, Minneapolis, MN — Minneapolis, Minnesota, United States
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE — Omaha, Nebraska, United States
- New Mexico VA Health Care System, Albuquerque, NM — Albuquerque, New Mexico, United States
- Durham VA Medical Center, Durham, NC — Durham, North Carolina, United States
- Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC — Salisbury, North Carolina, United States
- Philadelphia MultiService Center, Philadelphia, PA — Philadelphia, Pennsylvania, United States
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA — Pittsburgh, Pennsylvania, United States
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX — Dallas, Texas, United States
- VA Salt Lake City Health Care System, Salt Lake City, UT — Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle Division, Seattle, WA — Seattle, Washington, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record